376 related articles for article (PubMed ID: 29548746)
1. Opposite Molecular Signatures of Depression in Men and Women.
Seney ML; Huo Z; Cahill K; French L; Puralewski R; Zhang J; Logan RW; Tseng G; Lewis DA; Sibille E
Biol Psychiatry; 2018 Jul; 84(1):18-27. PubMed ID: 29548746
[TBL] [Abstract][Full Text] [Related]
2. Whole-transcriptome brain expression and exon-usage profiling in major depression and suicide: evidence for altered glial, endothelial and ATPase activity.
Pantazatos SP; Huang YY; Rosoklija GB; Dwork AJ; Arango V; Mann JJ
Mol Psychiatry; 2017 May; 22(5):760-773. PubMed ID: 27528462
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional profiling of mitochondria associated genes in prefrontal cortex of subjects with major depressive disorder.
Wang Q; Dwivedi Y
World J Biol Psychiatry; 2017 Dec; 18(8):592-603. PubMed ID: 27269743
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in alpha-[(11)C]MTrp brain trapping, an index of serotonin synthesis, in medication-free individuals with major depressive disorder: a positron emission tomography study.
Frey BN; Skelin I; Sakai Y; Nishikawa M; Diksic M
Psychiatry Res; 2010 Aug; 183(2):157-66. PubMed ID: 20630715
[TBL] [Abstract][Full Text] [Related]
5. Network-based approach to identify molecular signatures in the brains of depressed suicides.
Zeng D; He S; Ma C; Wen Y; Song W; Xu Q; Zhao N; Wang Q; Yu Y; Shen Y; Huang J; Li H
Psychiatry Res; 2020 Dec; 294():113513. PubMed ID: 33137553
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathology associated with altered synaptic transcriptome in the dorsolateral prefrontal cortex of depressed subjects.
Yoshino Y; Roy B; Kumar N; Shahid Mukhtar M; Dwivedi Y
Transl Psychiatry; 2021 Jan; 11(1):73. PubMed ID: 33483466
[TBL] [Abstract][Full Text] [Related]
7. Single-Nucleus Transcriptome Profiling of Dorsolateral Prefrontal Cortex: Mechanistic Roles for Neuronal Gene Expression, Including the 17q21.31 Locus, in PTSD Stress Response.
Chatzinakos C; Pernia CD; Morrison FG; Iatrou A; McCullough KM; Schuler H; Snijders C; Bajaj T; DiPietro CP; Soliva Estruch M; Gassen NC; Anastasopoulos C; Bharadwaj RA; Bowlby BC; Hartmann J; Maihofer AX; Nievergelt CM; Ressler NM; Wolf EJ; ; ; ; Carlezon WA; Krystal JH; Kleinman JE; Girgenti MJ; Huber BR; Kellis M; Logue MW; Miller MW; Ressler KJ; Daskalakis NP
Am J Psychiatry; 2023 Oct; 180(10):739-754. PubMed ID: 37491937
[TBL] [Abstract][Full Text] [Related]
8. Cell type specific transcriptomic differences in depression show similar patterns between males and females but implicate distinct cell types and genes.
Maitra M; Mitsuhashi H; Rahimian R; Chawla A; Yang J; Fiori LM; Davoli MA; Perlman K; Aouabed Z; Mash DC; Suderman M; Mechawar N; Turecki G; Nagy C
Nat Commun; 2023 May; 14(1):2912. PubMed ID: 37217515
[TBL] [Abstract][Full Text] [Related]
9. Cortical structural differences in major depressive disorder correlate with cell type-specific transcriptional signatures.
Li J; Seidlitz J; Suckling J; Fan F; Ji GJ; Meng Y; Yang S; Wang K; Qiu J; Chen H; Liao W
Nat Commun; 2021 Mar; 12(1):1647. PubMed ID: 33712584
[TBL] [Abstract][Full Text] [Related]
10. Sex-specific transcriptional signatures in human depression.
Labonté B; Engmann O; Purushothaman I; Menard C; Wang J; Tan C; Scarpa JR; Moy G; Loh YE; Cahill M; Lorsch ZS; Hamilton PJ; Calipari ES; Hodes GE; Issler O; Kronman H; Pfau M; Obradovic ALJ; Dong Y; Neve RL; Russo S; Kazarskis A; Tamminga C; Mechawar N; Turecki G; Zhang B; Shen L; Nestler EJ
Nat Med; 2017 Sep; 23(9):1102-1111. PubMed ID: 28825715
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome-based polygenic score links depression-related corticolimbic gene expression changes to sex-specific brain morphology and depression risk.
Miles AE; Dos Santos FC; Byrne EM; Renteria ME; McIntosh AM; Adams MJ; Pistis G; Castelao E; Preisig M; Baune BT; Schubert KO; Lewis CM; Jones LA; Jones I; Uher R; Smoller JW; Perlis RH; Levinson DF; Potash JB; Weissman MM; Shi J; Lewis G; Penninx BWJH; Boomsma DI; Hamilton SP; ; Sibille E; Hariri AR; Nikolova YS
Neuropsychopharmacology; 2021 Dec; 46(13):2304-2311. PubMed ID: 34588609
[TBL] [Abstract][Full Text] [Related]
12. Replicable and Coupled Changes in Innate and Adaptive Immune Gene Expression in Two Case-Control Studies of Blood Microarrays in Major Depressive Disorder.
Leday GGR; Vértes PE; Richardson S; Greene JR; Regan T; Khan S; Henderson R; Freeman TC; Pariante CM; Harrison NA; ; Perry VH; Drevets WC; Wittenberg GM; Bullmore ET
Biol Psychiatry; 2018 Jan; 83(1):70-80. PubMed ID: 28688579
[TBL] [Abstract][Full Text] [Related]
13. Regional brain volume in depression and anxiety disorders.
van Tol MJ; van der Wee NJ; van den Heuvel OA; Nielen MM; Demenescu LR; Aleman A; Renken R; van Buchem MA; Zitman FG; Veltman DJ
Arch Gen Psychiatry; 2010 Oct; 67(10):1002-11. PubMed ID: 20921116
[TBL] [Abstract][Full Text] [Related]
14. Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression.
Guilloux JP; Douillard-Guilloux G; Kota R; Wang X; Gardier AM; Martinowich K; Tseng GC; Lewis DA; Sibille E
Mol Psychiatry; 2012 Nov; 17(11):1130-42. PubMed ID: 21912391
[TBL] [Abstract][Full Text] [Related]
15. Parallel molecular alteration between Alzheimer's disease and major depressive disorder in the human brain dorsolateral prefrontal cortex: an insight from gene expression and methylation profile analyses.
Rastad S; Barjaste N; Lanjanian H; Moeini A; Kiani F; Masoudi-Nejad A
Genes Genet Syst; 2023 Apr; 97(6):311-324. PubMed ID: 36928034
[TBL] [Abstract][Full Text] [Related]
16. Integrative omics analysis identifies differential biological pathways that are associated with regional grey matter volume changes in major depressive disorder.
Sha Z; Banihashemi L
Psychol Med; 2022 Apr; 52(5):924-935. PubMed ID: 32723400
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive regional analysis of genome-wide expression profiles for major depressive disorder.
Forero DA; Guio-Vega GP; González-Giraldo Y
J Affect Disord; 2017 Aug; 218():86-92. PubMed ID: 28460316
[TBL] [Abstract][Full Text] [Related]
18. Gray matter volume and rapid decision-making in major depressive disorder.
Nakano M; Matsuo K; Nakashima M; Matsubara T; Harada K; Egashira K; Masaki H; Takahashi K; Watanabe Y
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():51-6. PubMed ID: 24076064
[TBL] [Abstract][Full Text] [Related]
19. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
[TBL] [Abstract][Full Text] [Related]
20. Machine learning and bioinformatic analysis of brain and blood mRNA profiles in major depressive disorder: A case-control study.
Qi B; Ramamurthy J; Bennani I; Trakadis YJ
Am J Med Genet B Neuropsychiatr Genet; 2021 Mar; 186(2):101-112. PubMed ID: 33645908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
